Harvey D. Preisler

Protected Environments and Prophylactic Antibiotics

Stuart E. Siegel, Alan D. Schreiber, Janet Hauser et al. · New England Journal of Medicine · 1973 · 327 citations

Medicine, Infectious Diseases, Oncology +15

Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study.

Harvey D. Preisler, RB Davis, Jeffrey J. Kirshner et al. · PubMed · 1987 · 298 citations

Medicine, Hematology, Oncology +9

An autopsy study of 1206 acute and chronic leukemias (1958 to 1982)

Maurice Barcos, Warren W. Lane, Germán A. Gómez et al. · Cancer · 1987 · 270 citations · Full text

Medicine, Hematology, Pathology +14

Membrane action of DMSO and other chemical inducers of Friend leukaemic cell differentiation

Gary H. Lyman, Harvey D. Preisler, Demetrios Papahadjopoulos · Nature · 1976 · 227 citations

Life Sciences, Biochemistry, Cell Biology +4

A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.

Amy Early, Harvey D. Preisler, Harry K. Slocum et al. · PubMed · 1982 · 190 citations

Medicine, Hematology, Pharmacology +16